Shilpa Medicare Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

813.15

-15.25 (-1.84%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

813.15

-15.25 (-1.84%)
16:02 Dec 20

Quality

79/100
High Financial Strength

Valuation

30/100
Expensive Valuation

Technical

51/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	901.13	1145.52	1050.11	1151.6	1214.48
Operating Expenses +	719.47	941.66	947.83	907.11	918.86
Raw Material	329.56	390.24	404.43	442.33	400.35
Increase Decrease in Cost	-58.83	-7.02	11.5	-34.78	8.02
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	235.31	264.49	287.33	281.49	283.83
Miscellaneous Expenses	234.79	310.93	312.55	254.09	226.66
Operating Profit	181.66	203.86	102.28	244.49	295.62
Other Income	30.14	14.25	17.4	8.17	19.13
Depreciation	53.98	79.8	95.5	107.87	108.73
Interest	21.87	41.17	58.65	91.81	99.71
Profit before tax and exceptio..	135.95	97.13	-34.47	52.99	106.31
Exceptional Items	60.84	8.79	0	6.13	6.13
PBT	196.79	105.93	-34.47	59.12	100.18
Provision for Taxation	48.85	41.68	-7.36	22.39	46.12
Net Profit	147.94	64.24	-27.11	36.73	66.32
NET Profit after MI	147.78	60.66	-32.48	31.87	61.08
EPS	18.13	7.26	-3.74	3.67	6.64
Operating Profit Margin (%)	20.16	17.8	9.74	21.23	24.34
Net Profit Margin (%)	16.4	5.3	-3.09	2.77	5.03

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	44.30	44.40	50.00	50.00	50.00
FII	9.60	9.10	5.60	8.50	8.60
MF	5.10	5.00	1.60	0.10	0.00
Public	37.90	38.90	42.70	41.40	41.00
Others	0.00	0.00	0.00	0.00	0.00
Others	3.10	2.60	0.10	0.00	0.40